5000456024686

Zoladeks is a medication produced by AstraZeneca UK Limited, containing the active ingredient goserelin acetate. It is available in two forms: Zoladeks 3.6 mg and Zoladeks 10.8 mg, both administered as subcutaneous implants. These implants are designed for long-term release and are typically used in the treatment of hormone-sensitive cancers, such as breast cancer in women and prostate cancer in men. (zoladex.com)

The barcode 5000456024686 corresponds to "Zoladeks ampul," which translates to "Zoladeks ampoule" in English. This suggests that the product is in liquid form, possibly for injection. However, the standard presentation of Zoladeks is as a subcutaneous implant, not an injectable solution. It's possible that "Zoladeks ampul" refers to a specific formulation or regional variant of the medication.

In Uzbekistan, Zoladeks is available in both 3.6 mg and 10.8 mg dosages. The 3.6 mg implant is priced at approximately 1,580,000 Uzbekistani som, while the 10.8 mg implant is priced at around 3,900,000 Uzbekistani som. (liki.uz)

As with all medications, Zoladeks may have side effects, including hot flashes, decreased libido, and injection site reactions. It's important to consult with a healthcare professional to determine if this medication is appropriate for your condition and to discuss potential risks and benefits.